Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study

Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study

Bibliographic Details
Main Authors:	Molinari, Chiara, Ballardini, Michela, Teodorani, Nazario, Giannini, Massimo, Zoli, Wainer, Emiliani, Ermanno, Lucci, Enrico, Passardi, Alessandro, Rosetti, Paola, Saragoni, Luca, Guidoboni, Massimo, Amadori, Dino, Calistri, Daniele
Format:	Online
Language:	English
Published:	BioMed Central 2011
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236016/

Similar Items

miR-17-92a-1 cluster host gene (MIR17HG) evaluation and response to neoadjuvant chemoradiotherapy in rectal cancer
by: Molinari, Chiara, et al.
Published: (2016)

EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab
by: CHIADINI, ELISA, et al.
Published: (2015)

Discrepancies between VEGF −1154 G>A Polymorphism Analysis Performed in Peripheral Blood Samples and FFPE Tissue
by: Marisi, Giorgia, et al.
Published: (2014)

Detection of KRAS mutant alleles in circulating cell-free tumor DNA in colorectal cancer patients resistant to cetuximab
by: Del Re, Marzia, et al.
Published: (2014)

Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: A single center study
by: Ulivi, Paola, et al.
Published: (2012)

Urine Cell-Free DNA Integrity as a Marker for Early Prostate Cancer Diagnosis: A Pilot Study
by: Casadio, Valentina, et al.
Published: (2013)

KRAS, BRAF and PIK3CA Status in Squamous Cell Anal Carcinoma (SCAC)
by: Casadei Gardini, Andrea, et al.
Published: (2014)

Neoadjuvant chemoradiotherapy for rectal cancer: how important is tumour regression?
by: McCoy, M., et al.
Published: (2015)

Delaying surgery after neoadjuvant chemoradiotherapy improves prognosis of rectal cancer
by: Mihmanlı, Mehmet, et al.
Published: (2016)

A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
by: Li, Yi, et al.
Published: (2016)

Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
by: Tokuhara, Katsuji, et al.
Published: (2016)

PET/CT with Fluorodeoxyglucose During Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
by: Travaini, Laura L, et al.
Published: (2016)

First evidence of a large CHEK2 duplication involved in cancer predisposition in an Italian family with hereditary breast cancer
by: Tedaldi, Gianluca, et al.
Published: (2014)

DNA Methylation profiles as predictors of recurrence in non muscle invasive bladder cancer: an MS-MLPA approach
by: Casadio, Valentina, et al.
Published: (2013)

eNOS polymorphisms as predictors of efficacy of bevacizumab-based chemotherapy in metastatic colorectal cancer: data from a randomized clinical trial
by: Ulivi, Paola, et al.
Published: (2015)

Correlation between tumor regression grade and rectal volume in neoadjuvant concurrent chemoradiotherapy for rectal cancer
by: Lee, Hong Seok, et al.
Published: (2016)

In vitro and in vivo evaluation of NCX 4040 cytotoxic activity in human colon cancer cell lines
by: Tesei, Anna, et al.
Published: (2005)

Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines
by: Tesei, Anna, et al.
Published: (2007)

Short Interfering RNA Directed against the SLUG Gene Increases Cell Death Induction in Human Melanoma Cell Lines Exposed to Cisplatin and Fotemustine
by: Vannini, Ivan, et al.
Published: (2007)

Chemoradiotherapy response in recurrent rectal cancer
by: Yu, Stanley K T, et al.
Published: (2014)

Promoter methylation of tumor suppressor genes in pre-neoplastic lesions; potential marker of disease recurrence
by: Rengucci, Claudia, et al.
Published: (2014)

Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer
by: McCoy, M., et al.
Published: (2015)

Manometric evaluation of anorectal function in patients treated with neoadjuvant chemoradiotherapy and total mesorectal excision for rectal cancer
by: De Nardi, Paola, et al.
Published: (2017)

MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
by: Svoboda, Marek, et al.
Published: (2012)

Negative impact of pretreatment anemia on local control after neoadjuvant chemoradiotherapy and surgery for rectal cancer
by: Lee, Hyebin, et al.
Published: (2012)

Value of transrectal ultrasonography for tumor node metastasis restaging in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy
by: Peng, Hai-Hua, et al.
Published: (2013)

Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis
by: Francesca De Felice, et al.
Published: (2017-05-01)

Loop ostomy following laparoscopic low anterior resection for rectal cancer after neoadjuvant chemoradiotherapy
by: Xin Wu, et al.
Published: (2018-05-01)

The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature
by: Anaïs Chauvin, et al.
Published: (2018-04-01)

Factors associated with rectal tumor and their influence on tumor regression grade after neoadjuvant chemoradiotherapy
by: Yu R Aliyarov
Published: (2018-08-01)

The Value of Restaging With Chest and Abdominal CT/MRI Scan After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
by: Liu, Guo-Chen, et al.
Published: (2015)

Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer Patients
by: Dreussi, Eva, et al.
Published: (2016)

Impact of age on efficacy of postoperative oxaliplatin-based chemotherapy in patients with rectal cancer after neoadjuvant chemoradiotherapy
by: Huang, Xuan-zhang, et al.
Published: (2016)

Treatment Interval between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer Patients: A Population-Based Study
by: Rombouts, A. J. M., et al.
Published: (2016)

Apparent Diffusion Coefficient Predicts Pathology Complete Response of Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy
by: Chen, Yuan-Gui, et al.
Published: (2016)

Elevated CA19-9 as the Most Significant Prognostic Factor in Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy
by: Zhang, Lu-Ning, et al.
Published: (2015)

Effect of Neoadjuvant Chemoradiotherapy with Capecitabine versus Fluorouracil for Locally Advanced Rectal Cancer: A Meta-Analysis
by: Liu, Guo-Chen, et al.
Published: (2016)

Tumor deposits: markers of poor prognosis in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy
by: Zhang, Lu-Ning, et al.
Published: (2015)

Pathological Assessment of Rectal Cancer after Neoadjuvant Chemoradiotherapy: Distribution of Residual Cancer Cells and Accuracy of Biopsy
by: Xiao, Lin, et al.
Published: (2016)

GRP78 Protein Expression as Prognostic Values in Neoadjuvant Chemoradiotherapy and Laparoscopic Surgery for Locally Advanced Rectal Cancer
by: Lee, Hee Yeon, et al.
Published: (2015)